Clinical Trial Update: Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Yale University is recruiting to investigate AMPA receptor components involved in the antidepressant response to ketamine in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: Yale University | Conditions: Depressive Disorder, Major, Post Traumatic Stress Disorder | Phase 1 | Status: RECRUITING